Published in Science on October 30, 2009
FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol Evol (2013) 2.73
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci U S A (2010) 2.59
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A (2012) 2.18
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotechnol (2009) 2.07
Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog (2011) 1.87
Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell (2013) 1.84
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol (2010) 1.83
Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses. PLoS Pathog (2013) 1.83
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
Norovirus GII.4 strain antigenic variation. J Virol (2010) 1.73
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70
Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity. Cell (2013) 1.64
Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One (2010) 1.56
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A (2010) 1.49
Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med (2013) 1.47
Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature (2015) 1.47
A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One (2011) 1.43
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc Natl Acad Sci U S A (2011) 1.40
Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing. BMC Genomics (2015) 1.38
Evolution of an Eurasian avian-like influenza virus in naïve and vaccinated pigs. PLoS Pathog (2012) 1.36
Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol (2011) 1.35
Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin. J Biol Chem (2010) 1.32
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J Clin Invest (2015) 1.27
The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology (2011) 1.25
Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS One (2011) 1.24
Immunity to seasonal and pandemic influenza A viruses. Microbes Infect (2011) 1.21
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol (2012) 1.20
Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS One (2010) 1.20
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model. PLoS Pathog (2013) 1.20
Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin. PLoS One (2010) 1.20
In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Viruses (2014) 1.17
Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol (2010) 1.15
Strength and tempo of selection revealed in viral gene genealogies. BMC Evol Biol (2011) 1.15
Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol (2011) 1.14
Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep (2011) 1.14
Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe (2013) 1.13
Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat Commun (2012) 1.12
Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry. PLoS Pathog (2012) 1.11
Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness. MBio (2014) 1.10
Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol (2010) 1.08
Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread. PLoS One (2013) 1.07
The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses. PLoS One (2011) 1.05
Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering. J Virol (2013) 1.04
Projection of seasonal influenza severity from sequence and serological data. PLoS Curr (2010) 1.03
Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS One (2010) 1.03
Viva la revolución: rethinking influenza a virus antigenic drift. Curr Opin Virol (2011) 1.02
Evaluation of Southern Hemisphere influenza vaccine recommendations. Vaccine (2010) 1.02
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin Virol (2014) 0.97
Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus. PLoS One (2013) 0.96
The roles of competition and mutation in shaping antigenic and genetic diversity in influenza. PLoS Pathog (2013) 0.95
Cross-species comparison of site-specific evolutionary-rate variation in influenza haemagglutinin. Philos Trans R Soc Lond B Biol Sci (2013) 0.95
Detecting patches of protein sites of influenza A viruses under positive selection. Mol Biol Evol (2012) 0.95
Generation and characterization of influenza A viruses with altered polymerase fidelity. Nat Commun (2014) 0.94
Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol (2013) 0.94
Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J Virol (2013) 0.94
Geometric Constraints Dominate the Antigenic Evolution of Influenza H3N2 Hemagglutinin. PLoS Pathog (2015) 0.92
Coordinated Evolution of Influenza A Surface Proteins. PLoS Genet (2015) 0.92
Compensatory evolution of net-charge in influenza A virus hemagglutinin. PLoS One (2012) 0.91
Increase in IFNγ(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza. PLoS One (2013) 0.91
Screening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions. PLoS One (2011) 0.89
Focused antibody response to influenza linked to antigenic drift. J Clin Invest (2015) 0.89
Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol (2014) 0.88
Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin. Virol J (2012) 0.88
The evolutionary dynamics of influenza A virus adaptation to mammalian hosts. Philos Trans R Soc Lond B Biol Sci (2013) 0.88
Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay. FEBS J (2011) 0.87
Towards multiscale modeling of influenza infection. J Theor Biol (2013) 0.87
Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody. PLoS One (2013) 0.86
Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol (2014) 0.85
Changes to the dynamic nature of hemagglutinin and the emergence of the 2009 pandemic H1N1 influenza virus. Sci Rep (2015) 0.85
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. J Virol (2010) 0.85
Pathogen evolution and the immunological niche. Ann N Y Acad Sci (2014) 0.85
Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design. Front Immunol (2011) 0.85
Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One (2011) 0.85
Highly pathogenic avian influenza virus subtype H5N1 escaping neutralization: more than HA variation. J Virol (2011) 0.85
Fitness Inference from Short-Read Data: Within-Host Evolution of a Reassortant H5N1 Influenza Virus. Mol Biol Evol (2015) 0.85
The effects of a deleterious mutation load on patterns of influenza A/H3N2's antigenic evolution in humans. Elife (2015) 0.85
Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses. J Virol (2013) 0.84
Predicting host tropism of influenza A virus proteins using random forest. BMC Med Genomics (2014) 0.84
Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans. J Virol (2016) 0.84
Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus. BMB Rep (2012) 0.83
Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets. Virology (2013) 0.83
The impact of host immune status on the within-host and population dynamics of antigenic immune escape. J R Soc Interface (2012) 0.83
How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example. J R Soc Interface (2014) 0.83
Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies. PLoS One (2016) 0.83
Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol (2016) 0.83
Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody. PLoS Pathog (2016) 0.82
Inference of genotype-phenotype relationships in the antigenic evolution of human influenza A (H3N2) viruses. PLoS Comput Biol (2012) 0.82
Time dependence of evolutionary metrics during the 2009 pandemic influenza virus outbreak. Virus Evol (2015) 0.82
Early cytokine dysregulation and viral replication are associated with mortality during lethal influenza infection. Viral Immunol (2014) 0.81
Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol (2015) 0.81
Reengineered AAV vectors: old dog, new tricks. Discov Med (2010) 0.81
Controlling influenza by cytotoxic T-cells: calling for help from destroyers. J Biomed Biotechnol (2010) 0.81
The evolutionary dynamics of receptor binding avidity in influenza A: a mathematical model for a new antigenic drift hypothesis. Philos Trans R Soc Lond B Biol Sci (2013) 0.81
Influenza vaccines: a moving interdisciplinary field. Viruses (2014) 0.81
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell (1982) 12.44
Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol (1990) 5.37
Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology (1997) 4.96
Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature (1979) 3.91
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci U S A (2006) 3.25
Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity. Virology (1998) 3.09
Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol (1986) 2.52
Evolving complexities of influenza virus and its receptors. Trends Microbiol (2008) 2.49
Variation and infectivity neutralization in influenza. Immunology (2006) 2.23
Mechanisms of neutralization of animal viruses. J Gen Virol (1984) 2.16
Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice. J Exp Med (1955) 2.05
Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology (2005) 1.91
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol (1987) 1.70
Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol (1986) 1.65
Antigenic variation in influenza viruses. Contrib Microbiol Immunol (1987) 1.32
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61
Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med (2008) 7.05
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity (2004) 6.72
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature (2005) 4.97
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol (2008) 4.37
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A (2009) 3.91
Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med (2004) 3.43
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A (2012) 3.27
Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol (2002) 3.22
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity (2003) 3.14
Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature (2004) 2.84
Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc Natl Acad Sci U S A (2008) 2.77
The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol (2003) 2.76
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci Transl Med (2011) 2.75
Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol (2005) 2.67
Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol (2008) 2.52
CD8+ T cell cross-priming via transfer of proteasome substrates. Science (2004) 2.51
Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature (2009) 2.50
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest (2005) 2.38
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology (2011) 2.28
HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc Natl Acad Sci U S A (2005) 2.11
Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics (2008) 2.09
Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods (2005) 2.06
Advancing glycomics: implementation strategies at the consortium for functional glycomics. Glycobiology (2006) 2.05
Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus. Nat Biotechnol (2009) 1.96
Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J Exp Med (2011) 1.95
Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PLoS One (2010) 1.95
Nuclear translation visualized by ribosome-bound nascent chain puromycylation. J Cell Biol (2012) 1.93
Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng (2006) 1.89
Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect (2008) 1.88
Modulating angiogenesis: the yin and the yang in ginseng. Circulation (2004) 1.86
Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell (2013) 1.84
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A (2012) 1.80
Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol (2007) 1.77
Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx. Am J Physiol Lung Cell Mol Physiol (2003) 1.76
HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J Immunol (2005) 1.75
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem (2005) 1.66
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice. J Virol (2006) 1.66
Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity. Cell (2013) 1.64
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host Microbe (2013) 1.62
Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J Biol Chem (2005) 1.62
Glycomics: a pathway to a class of new and improved therapeutics. Nat Rev Drug Discov (2004) 1.61
Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death. Chem Biol (2004) 1.61
Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog (2010) 1.57
Influenza A virus hemagglutinin trimerization completes monomer folding and antigenicity. J Virol (2013) 1.56
Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J Biol Chem (2006) 1.55
Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol (2005) 1.54
The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation. Innate Immun (2010) 1.53
Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J Biol Chem (2002) 1.53
Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J Immunol (2002) 1.51
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood (2007) 1.49
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc Natl Acad Sci U S A (2002) 1.49